Related Experiment Video
Updated: Jul 5, 2026
07:42
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Tyrosine kinase activating mutations in human malignancies: implications for diagnostic pathology
Joseph A Holden1, Carlynn Willmore-Payne, Lester J Layfield
1Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA.
Experimental and Molecular Pathology
|May 20, 2008
Summary
Activated tyrosine kinases drive cancer growth by promoting cell proliferation and blocking cell death. Targeting these kinases offers new therapeutic strategies and diagnostic tools for human malignancies, potentially improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Constitutively activated tyrosine kinases are crucial drivers in human cancers.
- Their signaling pathways promote uncontrolled cell proliferation and inhibit apoptosis, contributing to malignancy.
- Targeted therapies against these kinases have shown promise in cancer treatment.
Purpose of the Study:
- To highlight the role of activated tyrosine kinases in human malignancies.
- To discuss the implications of targeting these kinases in cancer therapeutics.
- To emphasize the diagnostic potential of identifying activated tyrosine kinases.
Main Methods:
- Review of current literature on tyrosine kinase signaling in cancer.
- Analysis of the impact of targeted kinase inhibitors on tumor regression.
- Discussion of advancements in molecular techniques for diagnostic characterization.
Main Results:
- Activated tyrosine kinases are key mediators of cancer cell growth and survival.
- Targeted inhibition of these kinases can lead to significant tumor regression.
- Molecular diagnostics can now identify activated tyrosine kinases in routine practice.
Conclusions:
- Activated tyrosine kinases are critical targets for novel cancer therapeutics.
- Identification of activated tyrosine kinases has predictive and prognostic value.
- Advancements in molecular diagnostics facilitate personalized cancer treatment strategies.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...